So, according to a 2024 Rand study, we've all seen the data, but prescription drug prices in the US are on average three times higher than in 33 other countries
Brett Osborn, a Florida neurologist and longevity expert, agreed that the availability of the first generic GLP-1 is "great news." The generics lower price point is particularly beneficial for people who have chronic conditions like diabetes, Osborn noted "where long-term medication use is necessary to prevent downrange effects like vascular disease, strokes and heart attacks , cancer, neurodegenerative diseases like Alzheimers, and obesity, the latter of which is also a gateway disease," he said
,
Coverage is shifting, compounded versions are disappearing, and out-of-pocket costs are soaring
You pull it out, examine the white powder inside, and wonder: is this still good